Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3

International Journal of Molecular Medicine

Volumn 28, Issue 6, 2011, Pages 1065-1069

  Hsieh, Tze Chen ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anti oxidative; Anti proliferative; Ganoderma lucidum; Lingzhi; OVCAR 3 cells; Phase II detoxification

Indexed keywords

CATALASE; CYCLIN D1; GANODERMA LUCIDUM EXTRACT; GLUTATHIONE TRANSFERASE P1; NAD(P)H:QUINONE OXIDOREDUCTASE 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DETOXIFICATION; DRUG EFFECT; FEMALE; GANODERMA LUCIDUM; HUMAN; HUMAN CELL; OVARY CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; CATALASE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OVARIAN NEOPLASMS; OXIDATIVE STRESS; PHYTOTHERAPY; REISHI; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRITERPENES; UP-REGULATION;

EID: 80053465054     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.788     Document Type: Article

References (27)

1. Holschneider CH and Berek JS: Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3-10, 2000. (Pubitemid 30439309)
2. La Vecchia C: Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 10: 125-129, 2001.
3. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
4. Yang MM, Chen Z and Kwok JS: The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV). Am J Chin Med 20: 221-232, 1992.
5. Wasser SP and Weis AL: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19: 65-96, 1999. (Pubitemid 29062102)
6. Borchers AT, Stern JS, Hackman RM, Keen CL and Gershwin ME: Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221: 281-293, 1999. (Pubitemid 29386016)
7. Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5: 4-27, 2000.
8. Hsieh TC, Wu P, Park S and Wu JM: Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP). BMC Complement Altern Med 6: 30, 2006.
9. Chu KK, Ho SS and Chow AH: Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol 42: 976-984, 2002. (Pubitemid 34920795)
10. Yue GG, Fung KP, Leung PC and Lau CB: Comparative studies on the immunomodulatory and antitumor activities of the different parts of fruiting body of Ganoderma lucidum and Ganoderma spores. Phytother Res 22: 1282-1291, 2008.
11. Lin ZB: Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99: 144-153, 2005.
12. Chang R: Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J Altern Complement Med 8: 559-565, 2002.
13. Chang R and White JD: Asian therapies for cancer - coming of age. J Altern Complement Med 8: 541-543, 2002. (Pubitemid 35291587)
14. Zaidman BZ, Yassin M, Mahajna J and Wasser SP: Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67: 453-468, 2005. (Pubitemid 40909591)
15. Chen HS, Tsai YF, Lin S, Lin CC, Khoo KH, Lin CH and Wong CH: Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem 12: 5595-5601, 2004. (Pubitemid 39304059)
16. Sliva D: Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem 4: 873-879, 2004.
17. Cheng KC, Huang HC, Chen JH, Hsu JW, Cheng HC, Ou CH, Yang WB, Chen ST, Wong CH and Juan HF: Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction. BMC Genomics 8: 411, 2007.
18. Jiang J, Slivova V and Sliva D: Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-κB signaling. Int J Oncol 29: 695-703, 2006.
19. Liu F, Ooi VE and Chang ST: Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci 60: 763-771, 1997. (Pubitemid 27087269)
20. Lakshmi B, Ajith TA, Jose N and Janardhanan KK: Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol 107: 297-303, 2006. (Pubitemid 44247443)
21. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR and Ozols RF: Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 43: 5379-5389, 1983. (Pubitemid 14230154)
22. Hsieh TC, Burfeind P, Laud K, Backer JM, Traganos F, Darzynkiewicz Z and Wu JM: Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol 15: 245-252, 1999.
23. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL and Wu JM: Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 337: 224-231, 2005. (Pubitemid 41393783)
24. Hsieh TC and Wu JM: Differential control of growth, cell cycle progression, and gene expression in human estrogen receptor positive MCF-7 breast cancer cells by extracts derived from polysaccharopeptide I'm-Yunity and Danshen and their combination. Int J Oncol 29: 1215-1222, 2006.
25. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM and Meadows GG: Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett 190: 157-163, 2003. (Pubitemid 36136014)
26. Shiao MS: Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec 3: 172-180, 2003.
27. Zhu M, Chang Q, Wong LK, Chong FS and Li RC: Triterpene anti-oxidants from Ganoderma lucidum. Phytother Res 13: 529-531, 1999.